Our mission is 'Coding cells for novel cures'. bit.bio combines the concepts of coding and biology to provide human cells for research, drug discovery and cell therapy.
bit.bio is a synthetic biology company focused on human cells, advancing medicine and enabling curative treatments. The company does this by industrialising the manufacture of human cells and making them more accessible.
bit.bio's opti-ox™ deterministic cell programming technology enables conversion of induced pluripotent stem cells into any desired human cell type in a single step, at industrial scale, while maintaining exceptional purity and consistency.
The company has a cell therapy pipeline, based on txCells, focused on serious diseases that lack effective treatments. The ioCells™ research cell product portfolio is opening up new possibilities in research and drug discovery.
Brands: Our portfolio of wild type and disease models ioCells includes: ioGlutamatergic Neurons, IoGlutamatergic Neurons HTT 50CAG/WT, IoGABAergic Neurons, ioSkeletal Myocytes.